Finckh, A. and Ciurea, A. and Brulhart, L. and Möller, B. and Walker, U. A. and Courvoisier, D. and Kyburz, D. and Dudler, J. and Gabay, C. and Arthritis, . (2010) Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent? Annals of the rheumatic diseases, Vol. 69, H. 2. pp. 387-393.
Full text not available from this repository.
Official URL: http://edoc.unibas.ch/dok/A6003965
Downloads: Statistics Overview
Abstract
Patients with rheumatoid arthritis (RA) with an inadequate response to TNF antagonists (aTNFs) may switch to an alternative aTNF or start treatment from a different class of drugs, such as rituximab (RTX). It remains unclear in which clinical settings these therapeutic strategies offer most benefit.
| Faculties and Departments: | 03 Faculty of Medicine > Bereich Medizinische Fächer (Klinik) > Rheumatologie 03 Faculty of Medicine > Departement Klinische Forschung > Bereich Medizinische Fächer (Klinik) > Rheumatologie |
|---|---|
| UniBasel Contributors: | Walker, Ulrich A. |
| Item Type: | Article, refereed |
| Article Subtype: | Research Article |
| Publisher: | British Medical Association |
| ISSN: | 0003-4967 |
| Note: | Publication type according to Uni Basel Research Database: Journal article |
| Related URLs: | |
| Identification Number: |
|
| Last Modified: | 21 Jun 2013 12:29 |
| Deposited On: | 21 Jun 2013 12:28 |
Repository Staff Only: item control page